Alector, Inc. Common Stock
Symbol: ALEC (NASDAQ)
2.86
▲ (2.29%) 0.064
Company Description:
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.
Key Stats
- Today's Open: $2.78
- Today's High: $2.877
- Today's Low: $2.765
- Today's Volume: 867.71K
- Yesterday Close: $2.8
- Yesterday High: $2.85
- Yesterday Low: $2.71
- Yesterday Volume: 673.95K
- Last Min Volume: 0
- Last Min High: $2.864
- Last Min Low: $2.844
- Last Min VWAP: $0
Company Profile
- Name: Alector, Inc. Common Stock
- Website: https://www.alector.com
- Listed Date: 2019-02-07
- Location: SOUTH SAN FRANCISCO, CA
- Market Status: Active
- CIK Number: 0001653087
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $279.35M
- Round Lot: 100
- Outstanding Shares: 101.21M
- Asset Type: CS
RECENT FILINGS FOR ALEC
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-04 | 4 | View |
| 2025-09-04 | 4 | View |
| 2025-09-04 | 4 | View |
| 2025-09-04 | 4 | View |
| 2025-08-29 | 144 | View |
| 2025-08-29 | 144 | View |
| 2025-08-29 | 144 | View |
| 2025-08-29 | 144 | View |
| 2025-08-27 | 4 | View |
| 2025-08-26 | 144 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-08 | 144 | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-06-30 | 3 | View |
| 2025-06-30 | 3 | View |
| 2025-06-23 | 4 | View |
Latest News on ALEC